Patients who gain weight during their first month on antidepressants are likely to gain even more pounds after three months, researchers in France report.

    READ MORE

The Brainsway Deep Transcranial Magnetic Stimulation (TMS) System can be marketed as a treatment for obsessive compulsive disorder (OCD), the US Food and Drug Administration (FDA) announced.

  READ MORE

Between 1 and 2 daily milligrams of adjunctive cariprazine eased depression more than placebo in patients with major depressive disorder, according to a newly published study.

  READ MORE

Psych Congress Steering Committee member Jon Draud, MD, MS, discusses the use of transcranial magnetic stimulation (TMS) in psychiatry, including its benefits, side effects, and potential applications.

  READ MORE

Michael Thase, MD, will review data on emerging medications for depression, outline the pathophysiology of depression, and discuss the limitations of available treatments in a session at the upcoming Psych Congress 2018 conference.

  READ MORE

Psych Congress Year-Round

Anticipate some significant changes in the treatment of schizophrenia over the next 10 years, from a move toward coordinated specialty care to harnessing the power of social media to help identify symptoms sooner, said John M. Kane, MD, who will speak on the topic at the upcoming Psych Congress.

Spotlight

COLUMBUS, Ohio—Psych Congress cochair Charles Raison, MD, gave attendees a “10,000-foot view” of what depression is at the Psych Congress Regionalsmeeting here, and will explore the idea more at the upcoming Psych Congress 2018 preconference.